about
Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasisThe Role of Forkhead Box Protein M1 in Breast Cancer Progression and Resistance to TherapyStathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancerMicroRNAs as regulators and mediators of forkhead box transcription factors function in human cancersFOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathwaysExploiting FOXM1-orchestrated molecular network for early squamous cell carcinoma diagnosis and prognosis3, 3'-Diindolylmethane enhances the effectiveness of herceptin against HER-2/neu-expressing breast cancer cellsSUMOylation inhibits FOXM1 activity and delays mitotic transition.Forkhead box M1 (FoxM1) gene is a new STAT3 transcriptional factor target and is essential for proliferation, survival and DNA repair of K562 cell lineNext-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank.FoxM1 mediated resistance to gefitinib in non-small-cell lung cancer cellsFOXM1 modulates cisplatin sensitivity by regulating EXO1 in ovarian cancerPrognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.Activating transcription factor 4 confers a multidrug resistance phenotype to gastric cancer cells through transactivation of SIRT1 expression.Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage.Suppression of the FOXM1 transcriptional programme via novel small molecule inhibitionMammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.Insulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1.Resistance to HER2-targeted therapies: a potential role for FOXM1.Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cellsUp-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer.The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cellsSorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1RERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer.Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia.FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis.The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNAFoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.Small molecule inhibition of FOXM1: How to bring a novel compound into genomic contextThe two faces of FBW7 in cancer drug resistance.FoxM1 regulates mammary luminal cell fateIdentification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells.A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESSFOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair.Stathmin involvement in the maternal embryonic leucine zipper kinase pathway in glioblastoma.
P2860
Q24613046-386569A1-986A-4A34-B1AB-CF050BD8CAC4Q26768290-20003F75-85E0-4B4E-87F4-EAFB0EADAF6BQ27852937-13781346-7358-47CB-BE5A-EABC66DC3E57Q28072056-1A0CC660-3C87-487B-B7D9-6C281911400EQ28076296-A2B89EC6-3DE9-4009-9592-25EAB0770F71Q28276344-E6EEEFDB-C1CE-4824-8A1B-830F7604244FQ28485231-4EC84D25-279D-4829-9A8E-22AC35805CB1Q30583585-F0D75BC9-ACE5-4700-9471-A78DA9651974Q31105943-870C1850-1287-4AE2-8257-7FAC601F693AQ33456377-99750D0C-03BB-49AE-87D9-9F87F8199736Q33567379-DEC8DF8A-F4FB-48E8-B4BF-942A74AABB59Q33605013-BF28D91E-A181-4323-94F3-B2B8950AF09FQ33762091-6993FBEF-712D-4FCD-8409-CFD3FEF69557Q33991617-6A1D8611-2B44-417F-AE9F-5BFEDAD24941Q34170941-97741272-065F-4CFF-B040-B2BD3EA7091AQ34185710-93B919A9-1A31-40DC-80F1-707AF7DBAA1BQ34649774-5A7EAA4A-0422-4E6A-8047-42AB81787596Q34664059-06F22362-1CA6-45F0-816D-55E2FABAA1C5Q34946846-E4DF7A4C-8BAA-4FD7-9394-6F4280003119Q34955355-4906F79D-6231-46BC-8B28-7F2D1FB102E8Q34956879-42630494-11E3-4E42-9161-A58AB9C421E8Q34998307-3D818269-D43C-4092-BF7A-2C02CFDECF5CQ35000256-6EA683AC-EE4E-405A-9C5D-A6C10028CCC3Q35080145-08B8AE21-F454-4C31-9884-2CBDF4C71434Q35103309-565606B1-3734-41D2-83C9-3C7410444AB8Q35168154-2E5415F4-2575-472B-8509-838DAD38C166Q35197045-089EB846-C8ED-4039-A78B-A481A2724968Q35273654-281C57F9-656B-47E6-9334-7FDCB9D49895Q35410253-87F29012-A145-4444-ACA8-4A349EFFB1E4Q35558134-F8F73EAA-BB28-4BF0-B84F-C9C8E6F7C53AQ35764362-1046BE4D-861D-49DB-A966-D770C76EDC4DQ35793788-AC2DE0CF-6B8D-4F17-8154-8F8CBFEE4B19Q35800767-8685227B-B379-495F-8ED1-D26A73FCD684Q35951768-8A949638-FAF3-47F8-BADF-7245BAD51265Q35999467-D4DD537A-290F-474C-93EE-CAD0194509C1Q36106731-821B378B-3EF4-43C7-BBC4-EF5125D2B08FQ36293810-28A19213-B965-40E0-801B-355DD2E10211Q36419222-34F5032C-2FB3-492D-8CD5-DCCAF4AFF553Q36486689-2129DCF3-50F0-4D49-8BFF-1CCDC32F0F22Q36679284-957EB1EE-89FB-4C4B-A050-1BEA1D9CF664
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
FoxM1 mediates resistance to herceptin and paclitaxel.
@ast
FoxM1 mediates resistance to herceptin and paclitaxel.
@en
type
label
FoxM1 mediates resistance to herceptin and paclitaxel.
@ast
FoxM1 mediates resistance to herceptin and paclitaxel.
@en
prefLabel
FoxM1 mediates resistance to herceptin and paclitaxel.
@ast
FoxM1 mediates resistance to herceptin and paclitaxel.
@en
P2093
P2860
P1433
P1476
FoxM1 mediates resistance to herceptin and paclitaxel
@en
P2093
Hyun Jung Park
Megan M Kiefer
Pradip Raychaudhuri
Zebin Wang
P2860
P304
P356
10.1158/0008-5472.CAN-10-0545
P407
P577
2010-06-08T00:00:00Z